Drug Shortage Report for TEVA-RIZATRIPTAN ODT

Last updated on 2021-04-15 History
Report ID 134340
Drug Identification Number 02396661
Brand name TEVA-RIZATRIPTAN ODT
Common or Proper name RIZATRIPTAN OD 5MG TABS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) RIZATRIPTAN
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size PP 6
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-02-17
Estimated end date 2021-04-30
Actual end date 2021-04-14
Shortage status Resolved
Updated date 2021-04-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2021-04-15 French Compare
v11 2021-04-15 English Compare
v10 2021-04-01 French Compare
v9 2021-04-01 English Compare
v8 2021-03-18 French Compare
v7 2021-03-18 English Compare
v6 2021-03-11 French Compare
v5 2021-03-11 English Compare
v4 2021-02-25 French Compare
v3 2021-02-25 English Compare
v2 2021-02-18 French Compare
v1 2021-02-18 English Compare

Showing 1 to 12 of 12